Research Keyword: Wnt signaling

Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products

mycolabadmin

This review examines a special group of fungal compounds called incisterols, with focus on demethylincisterol A3 (DM-A3), which shows promise as a cancer-fighting agent. DM-A3 works through multiple mechanisms: it blocks cancer cell growth pathways, inhibits specific cancer-promoting proteins, and has anti-inflammatory effects. The compound has shown strong activity against various cancer types in laboratory and animal studies, making it a candidate for further development as a potential cancer therapy.

Read More »

Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products

mycolabadmin

This review examines a group of rare fungal compounds called incisterols, with a focus on demethylincisterol A3 (DM-A3), which has shown promise as an anticancer agent. DM-A3 works through multiple mechanisms including blocking cancer cell signaling pathways, inhibiting specific enzymes, and reducing inflammation. The compound has demonstrated effectiveness against various cancer types in laboratory studies and showed tumor-reducing effects in animal models, suggesting potential for future cancer therapy development.

Read More »

Axin2 coupled excessive Wnt-glycolysis signaling mediates social defect in autism spectrum disorders

mycolabadmin

Autism spectrum disorder affects social abilities in millions of people, but the underlying causes remain poorly understood. This research discovered that in the brains of people with autism, certain cellular processes that control energy and signaling become overactive, particularly in the region controlling social behavior. The good news is that the researchers found a drug-like compound called XAV939 can restore normal function by blocking the abnormal interaction between two key proteins, potentially offering a new treatment approach.

Read More »

Polysacharide of Agaricus blazei gel mitigates bone necrosis in model of the jaws related to bisphosphonate via Wnt signaling

mycolabadmin

This study tested whether a gel made from Agaricus blazei mushroom could help repair jaw bone damage caused by bisphosphonate medications (used to treat bone loss). Using a rat model, researchers found that the mushroom gel significantly improved bone healing by activating biological pathways that promote bone-forming cell growth and activity. The treatment increased the number of living bone cells, improved bone quality, and reduced bone death and tissue damage. These promising results suggest the mushroom extract could become a helpful treatment to prevent or manage jawbone damage in patients taking bisphosphonate medications.

Read More »
Scroll to Top